Get the Stockscreener App
293.46
0.57%
1.66
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $293.46, with a volume of 761.53K.
It is up +0.57% in the last 24 hours and down -0.79% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
See More
Previous Close:
$291.80
Open:
$293.57
24h Volume:
761.53K
Relative Volume:
0.48
Market Cap:
$77.63B
Revenue:
$278.13B
Net Income/Loss:
$6.74B
P/E Ratio:
12.43
EPS:
23.6047
Net Cash Flow:
$7.66B
1W Performance:
+1.98%
1M Performance:
-0.79%
6M Performance:
+5.20%
1Y Performance:
-4.96%
1-Day Range:
$289.31
$294.23
1-Week Range:
$275.80
$296.60
52-Week Range:
$239.51
$315.47
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
293.46 | 77.63B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
424.62 | 385.62B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.15 | 132.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
416.23 | 90.39B | 200.42B | 5.24B | 6.45B | 23.50 |
HUM
Humana Inc
|
392.22 | 47.09B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Cigna Group stock holds steady on its business mix - ad-hoc-news.de
Built with America: The Cigna Group’s 230-year history of innovation in service of customers - The Cigna Group Newsroom
Cigna Group (NYSE: CI) officer Bryan Holgerson details stock, 401(k) and option positions in Form 3 - Stock Titan
Cigna Group (NYSE: CI) officer Adam Kautzner details stock and option holdings - Stock Titan
Cigna Group (NYSE: CI) officer Jason Sadler reports share and option holdings - Stock Titan
Cigna Group (CI) officer Sanford Paul A reports holding 4,073 common shares - Stock Titan
Cigna Group (NYSE: CI) officer Matthew Perlberg reports initial stock and option holdings - Stock Titan
CI Maintained by Bernstein -- Price Target Raised to $381 - GuruFocus
What to Expect From Cigna's Next Quarterly Earnings Report - Yahoo Finance
Bernstein Adjusts Price Target on Cigna Group to $381 From $371 - marketscreener.com
Bernstein raises Cigna stock price target to $381 on earnings outlook - Investing.com
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
CIGNA (CI) PT Raised to $381 at Bernstein SocGen Group - StreetInsider
Independent Pharmacies Accuse Prime Therapeutics of Price-Fixing Scheme With Express Scripts - Benzinga
Lawmakers Target the Power of Health Insurance Giants - The New York Times
Did Cigna's (CI) US$100 Million AI Pharmacy Bet Just Rewire Its Specialty-Care Narrative? - simplywall.st
Hope House Accepts Cigna, Aetna & UMR for Scottsdale Rehab - The Malone Telegram
Hope House Integrates UMR, Cigna & Aetna Into Admissions - The Malone Telegram
Another Wave Of Double-Digit Obamacare Rate Hikes Coming For 2027 - Forbes
Cigna Group focuses on health benefits growth as investors watch the US managed-care sector - Ad-hoc-news.de
The Cigna Group Foundation Launches 2026 Grant Program to Support Veterans - AOL.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges - Investing.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges By Investing.com - Investing.com Canada
Cigna Group stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Josh Michelson Appointed Executive Vice President, Chief Strategy and Innovation Officer at The Cigna Group - hrtoday.in
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock’s Asembia Buy - Forbes
The Cigna Group sets July 30 earnings call, webcast and replay - Stock Titan
Cigna Group focuses on health benefits and steady operations - ad-hoc-news.de
Cigna Group (CI) Could Be 17% Undervalued On Its $100 Million Evernorth AI Push - simplywall.st
Cigna Group stock underperforms Monday when compared to competitors - MarketWatch
The Cigna Group highlights its health services model as investors track long-term growth potential - ad-hoc-news.de
Prime Therapeutics Accused of Deflating Pharmacy Pay Rates (1) - Bloomberg Law News
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off? - TradingView
Cigna slips as investors weigh PBM transition and a lack of fresh catalysts - Quiver Quantitative
Cigna Group outlines its role in US health coverage and benefits - ad-hoc-news.de
Cigna Group (CI) Stock Analysis: Unpacking an 18% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Cigna (CI) Stock Just Lost Its Place In Key Russell Growth Indexes - Yahoo Finance
Cigna (CI) Stock Still Looks Cheap As Earnings Stay Strong - Yahoo Finance
Cigna (CI) Launches AI Pharmacy Program With $100 Million Behind It - simplywall.st
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders - Yahoo Finance
The Cigna Group focuses on health services growth as investors watch its stock - ad-hoc-news.de
Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward - Yahoo Finance Singapore
Goldman Sachs Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $340 - 富途牛牛
New Cigna CEO’s patient-first focus to face Wall Street test - Crain's New York
CICigna Group Volatility & Greeks - Finviz
Top Cigna Group (CI) Competitors 2026 - MarketBeat
Cigna's Evernorth division announces $100M specialty drug AI program - BenefitsPRO
Evernorth Invests $100M for AI Specialty Pharmacy Program - MedCity News
Evernorth Launches AI-Driven Specialty Care Initiative Backed by $100M Investment - citybiz
Cigna Group outlines growth strategy as health benefits demand evolves - AD HOC NEWS
Cigna (CI) Unveils $100M AI-Driven Specialty Care Program to Enh - GuruFocus
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cigna Group Stock (CI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kates Jamie G | Chief Accounting Officer |
Jun 12 '26 |
Sale |
298.61 |
899 |
268,452 |
2,368 |
0.99%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):